SV

Street Verdict

Analyst Scorecard

A record of what Avinash Gorakshkar said publicly, with the source. Not advice.

Pending — not yet graded
“Bullish on Indian pharma stocks like Zydus Life, Aurobindo Pharma, Dr Reddy's Lab, Lupin, Sun Pharma, Cipla, and Gland Pharma, expecting a sharp rebound on Monday. These stocks were heavily beaten on Friday due to panic over Trump's tariffs, but the tariffs are conditional on branded drugs, which Indian companies largely avoid as they export generics.”
Nifty PharmaBullishCalled 27 Sep 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Avinash Gorakshkar’s full track record